Blood Flow Restriction Clinical Trial
Official title:
The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone
NCT number | NCT04079010 |
Other study ID # | 57 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 4, 2019 |
Est. completion date | November 25, 2019 |
Verified date | March 2020 |
Source | University of Mary Hardin-Baylor |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The current study will investigate the effects of Blood Flow Restriction (BFR) training and L-arginine supplementation on recreationally trained female participants. In particular, it will compare performance outcomes and blood markers among two intervention groups (BFR and BFR+Arg) and a control group (CON).
Status | Completed |
Enrollment | 30 |
Est. completion date | November 25, 2019 |
Est. primary completion date | November 25, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 25 Years |
Eligibility |
Inclusion Criteria: - Signed informed consent - PAR-Q form complete and without contraindications - Body Mass Index (BMI) of 18.5-29.9 kg/m2 - Stable body weight prior to participation in the study (fluctuation not exceeding 10 lbs. within the past 6 months - Agreement not to change current diet or exercise program (other than adding the program for the purpose of this study) Exclusion Criteria: - Any diagnosed orthopedic condition that prevents exercise - BMI > 29.9 kg/m2 or < 18.5 kg/m2 - Affirmative answer to any of the questions presented on the PAR-Q form - Are currently pregnant or planning to become pregnant during the study - Currently taking blood pressure medication |
Country | Name | City | State |
---|---|---|---|
United States | University of Mary Hardin-Baylor | Belton | Texas |
Lead Sponsor | Collaborator |
---|---|
University of Mary Hardin-Baylor |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cortisol | Cortisol will be assessed by blood draw in an acute response design | Measured at Week 0, Week 4, and Week 8 at the following intervals: prior to supplement, 15 and 30 minutes post-supplementation (before exercise), and 90 minutes post-supplementation (after exercise) | |
Primary | Strength | 1 RM (rep-max) will be utilized to measure lower extremity strength | Baseline measurements will be obtained during Week 0, then measurements will be taken at Week 4 and Week 8 to determine the amount of change in participant's strength at those particular time points compared to baseline | |
Secondary | Growth Factor | Growth Hormone will be assessed by blood draw in an acute response design | Measured at Week 0, Week 4, and Week 8 at the following intervals: prior to supplement, 15 and 30 minutes post-supplementation (before exercise), and 90 minutes post-supplementation (after exercise) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06171841 -
Effects of Low-Intensity Blood Flow Restriction Training in Normoxia and Hypoxia Conditions
|
N/A | |
Withdrawn |
NCT04977804 -
Eccentric Resistance Training With Blood Flow Restriction on Muscle Function
|
N/A | |
Completed |
NCT04270695 -
Blood Flow Restriction Training Combined With Abdominal draw-in Maneuver on Transverse Abdominis Strengthening
|
N/A | |
Not yet recruiting |
NCT05606744 -
Effects of Blood Flow Restriction During Eccentric Resistance Exercise
|
N/A | |
Recruiting |
NCT04384120 -
BFR Therapy in Patients With Rotator Cuff Tears
|
N/A | |
Completed |
NCT04996680 -
Vascular Occlusion for Optimizing Functional Improvement in Patients With Knee Osteoarthritis
|
N/A | |
Completed |
NCT05177952 -
Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT04285879 -
Blood Flow Restriction Training (BFR) in an Adolescent Population
|
N/A |